Tus kws kho mob
QP66-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2871 - 2880 ntawm 4269
Tus kws kho mob
QP65-25 Commercial Pharmacy Benefit Exclusion for Select Medications
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tus kws kho mob
QP64-25 Commercial Pharmacy Benefit Exclusion for Enflonsia™, Imuldosa™, Osenvelt®, Stoboclo®, Yeztugo® and Zusduri™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tus kws kho mob
QP63-25 MHCP Pharmacy Benefit Exclusion for Enflonsia™, Lynozyfic™ and Zusduri™
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tus kws kho mob
QP61-25 Change in Replacement Claim Processing
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tus kws kho mob
QP45R1-25 Multiple Medicaid Coverages Listed on the Same Claim
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025
Tus kws kho mob
QP68-25 MHCP Process for Behavioral Health Residential Prior Authorization (PA) Submission
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 13, 2025